Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
5.03
-0.27 (-5.09%)
Apr 29, 2026, 1:22 PM EDT - Market open
Zura Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
| Net Income | -68.65 | -52.4 | -60.36 | -28.08 | -46.91 |
| Depreciation & Amortization | 0.05 | 0.01 | - | - | - |
| Asset Writedown & Restructuring Costs | - | - | 27.38 | 23.88 | - |
| Stock-Based Compensation | 12.33 | 16.8 | 9.66 | 0.36 | - |
| Other Operating Activities | -4.91 | 5.21 | 3.15 | -1.34 | 45 |
| Change in Accounts Payable | -2.16 | 4.21 | 5.94 | 4.09 | 0.23 |
| Change in Other Net Operating Assets | -1.47 | -1.91 | -0.83 | -0.23 | - |
| Operating Cash Flow | -64.82 | -28.08 | -15.05 | -1.31 | -1.68 |
| Capital Expenditures | -0.11 | -0.08 | - | - | - |
| Sale (Purchase) of Intangibles | - | -5 | -8 | -13.09 | -30 |
| Investing Cash Flow | -0.11 | -5.08 | -8 | -13.09 | -30 |
| Total Debt Issued | - | - | - | 8.29 | - |
| Short-Term Debt Repaid | - | - | -10 | - | - |
| Total Debt Repaid | - | - | -10 | - | - |
| Net Debt Issued (Repaid) | - | - | -10 | 8.29 | - |
| Issuance of Common Stock | 5.4 | 68.16 | 120.61 | - | - |
| Repurchase of Common Stock | -0.04 | -0.32 | - | - | - |
| Other Financing Activities | -7.53 | 42 | 10.69 | -3.09 | - |
| Financing Cash Flow | -2.16 | 109.84 | 121.29 | 16.11 | 60 |
| Net Cash Flow | -67.09 | 76.69 | 98.24 | 1.71 | 28.32 |
| Free Cash Flow | -64.93 | -28.15 | -15.05 | -1.31 | -1.68 |
| Free Cash Flow Per Share | -0.69 | -0.38 | -0.46 | -5.75 | - |
| Levered Free Cash Flow | -42.52 | -24.76 | -25.08 | - | - |
| Unlevered Free Cash Flow | -42.52 | -24.76 | -25.08 | - | - |
| Change in Working Capital | -3.63 | 2.31 | 5.12 | 3.86 | 0.23 |
Source: S&P Capital IQ. Standard template.
Financial Sources.